These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 4927915)

  • 41. Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia.
    Bell NH; Avery S; Johnston CC
    J Clin Endocrinol Metab; 1970 Sep; 31(3):283-90. PubMed ID: 4916538
    [No Abstract]   [Full Text] [Related]  

  • 42. [Problems concerning clinical application of calcitonin].
    Morii H
    Nihon Rinsho; 1972 Mar; 30(3):759-65. PubMed ID: 4556796
    [No Abstract]   [Full Text] [Related]  

  • 43. Calcium and phosphorus metabolism parathyroid hormone, calcitonin and bone histology in pseudohypoparathyroidism.
    Birkenhäger JC; Seldenrath HJ; Hackeng WH; Schellekens AP; van der Veer AL; Roelfsema F
    Eur J Clin Invest; 1973 Jan; 3(1):27-34. PubMed ID: 4347095
    [No Abstract]   [Full Text] [Related]  

  • 44. Calcium and phosphate metabolism and the bone.
    Morgan DB
    Prog Surg; 1972; 10():24-75. PubMed ID: 4598505
    [No Abstract]   [Full Text] [Related]  

  • 45. The acute response to calcitonin in Paget's disease: its relationship to the serum alkaline phosphatase level and the effect of phosphate treatment.
    Gershberg H; Girgis M; Goldberg L; Duga J; St Paul H
    J Clin Endocrinol Metab; 1973 Apr; 36(4):691-6. PubMed ID: 4686375
    [No Abstract]   [Full Text] [Related]  

  • 46. Correlation between mass of parathyroid adenoma and biochemical indicators of bone turnover in patients with primary hyperparathyroidism.
    Broulík PD; Stĕpán JJ; Hradec E; Marek J; Pacovský V
    Exp Clin Endocrinol; 1986 Dec; 88(3):360-4. PubMed ID: 3556419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Parathyroid hormone secretion in primary hyperparathyroidism.
    Bouillon R; de Moor P
    J Clin Endocrinol Metab; 1977 Aug; 45(2):261-9. PubMed ID: 407239
    [No Abstract]   [Full Text] [Related]  

  • 48. Role of kidney in regulation of plasma-calcium.
    Nordin BE; Peacock M
    Lancet; 1969 Dec; 2(7633):1280-3. PubMed ID: 4187984
    [No Abstract]   [Full Text] [Related]  

  • 49. [Interrelation between parathyroid hormone and calcitonin in calcium homeostasis].
    Morii H
    Nihon Naibunpi Gakkai Zasshi; 1970 Nov; 46(8):870-1. PubMed ID: 5530963
    [No Abstract]   [Full Text] [Related]  

  • 50. [Normocalcemic fibrocystic osteitis. Apropos of an observation. Diagnostic problem and pathogenic interest].
    Dorfmann H; Bordier P; Figueroa M; de Sèze S
    Ann Med Interne (Paris); 1973 Mar; 124(3):217-23. PubMed ID: 4716714
    [No Abstract]   [Full Text] [Related]  

  • 51. Bone, calcium, and hydroxyproline metabolism in hyperparathyroidism and after removal of parathyroid adenoma.
    Laitinen O
    Acta Med Scand; 1977; 202(1-2):39-42. PubMed ID: 899881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypoparathyroidism and Paget's disease: the effect of parathyroid hormone administration.
    Genuth SM; Klein L
    J Clin Endocrinol Metab; 1972 Nov; 35(5):693-9. PubMed ID: 4262771
    [No Abstract]   [Full Text] [Related]  

  • 53. [Thyrocalcitonin and its clinical use].
    Migunova NA; Nikiforova NV; Ermolenko VM; Briskin AI
    Sov Med; 1973 Apr; 36(4):34-8. PubMed ID: 4588905
    [No Abstract]   [Full Text] [Related]  

  • 54. [Role of the kidney in calcium homeostasis].
    Morgan DB
    Z Gesamte Inn Med; 1972 Apr; 27(8):337-42. PubMed ID: 4626557
    [No Abstract]   [Full Text] [Related]  

  • 55. Normocalcemic secondary hyperparathyroidism and malabsorption.
    Fischer JA; Binswanger U; Schenk R; Merz W; Kistler HJ
    Helv Med Acta; 1969 May; 35(1):30-42. PubMed ID: 5772693
    [No Abstract]   [Full Text] [Related]  

  • 56. Attempts to prevent disuse osteoporosis by treatment with calcitonin, longitudinal compression and supplementary calcium and phosphate.
    Hantman DA; Vogel JM; Donaldson CL; Friedman R; Goldsmith RS; Hulley SB
    J Clin Endocrinol Metab; 1973 May; 36(5):845-58. PubMed ID: 4698244
    [No Abstract]   [Full Text] [Related]  

  • 57. [Human calcitonin in the treatment of symptomatic Paget's disease].
    Mathä R; Kovarik J; Woloszczuk W; Plenk H; Willvonseder R; Böhler N; Seidl G; Höfer R
    Aktuelle Gerontol; 1983 Jan; 13(1):10-4. PubMed ID: 6131616
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parathyroid hormone and thyrocalcitonin function in adrenalectomized rats.
    Talmage RV; Kennedy JW
    Endocrinology; 1970 May; 86(5):1075-9. PubMed ID: 5435248
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
    Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
    [No Abstract]   [Full Text] [Related]  

  • 60. [Ultimobranchial or calcitonic osteopathies].
    Szántó D
    Z Gesamte Inn Med; 1973 Apr; 28(8):227-32. PubMed ID: 4716920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.